---  
layout: startup_page  
title: "Armatus Bio"  
id: "armatusbio.com"  
permalink: "/armatusbioarmatusbio.com05062025/"  
website: "https://armatusbio.com"  
funding_round: "Strategic Investment"  
funding_amount: "$3M"  
investors: "SOLVE FSHD"  
about: "Armatus Bio is a biotechnology company developing next-generation vectorized RNAi therapeutics for neuromuscular diseases, specifically targeting the genetic cause of FSHD. Their lead program, ARM-201, aims to silence the expression of DUX4, the toxic protein responsible for muscle degeneration in individuals with FSHD. The company is focused on precision medicines to transform care for people with genetic neuromuscular disorders."  
markets: "Biotech, Healthtech, Biopharma, Biotechnology, Health Diagnostics, Drug Discovery, Life Sciences"  
hq: "Columbus, Ohio, United States"  
founded_year: "2020"  
linkedin: "https://www.linkedin.com/company/armatusbio"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/armatus-bio"  
pitchbook: "https://pitchbook.com/profiles/company/483842-62"  

date_display: "06-May-2025"  
date: "2025-05-06"

# SEO Optimization  
meta_title: "Armatus Bio - Strategic Investment Funding ($3M)"  
meta_description: "Armatus Bio, Armatus Bio is a biotechnology company developing next-generation vectorized RNAi therapeutics for neuromuscular diseases, specifically targeting the ..."  
meta_keywords: "Armatus Bio, Biotech, Healthtech, Biopharma, Biotechnology, Health Diagnostics, Drug Discovery, Life Sciences, Strategic Investment funding"  
canonical_url: "https://startup.projectstartups.com/armatusbioarmatusbio.com05062025/"  
---